Immune Modulation During Palynziq® Treatment in Adults (IMPALA)
for Phenylketonuria
12 locations incl. Los Angeles
Sponsor: BioMarin Pharmaceutical
Sex: All·Age: 18 - 65
Code: NCT07477691·Phase 4·Recruiting·Listed Mar 2026
University of Pittsburgh Medical Center (UPMC) - Children's Hospital of Pittsburgh
Clinical research site in Philadelphia, Pennsylvania
Part of University of Pittsburgh Medical Center
As of July 2026, 1 paid clinical trial is recruiting at University of Pittsburgh Medical Center (UPMC) - Children's Hospital of Pittsburgh in Philadelphia, Pennsylvania. Active studies at this site focus on Phenylketonuria alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at University of Pittsburgh Medical Center (UPMC) - Children's Hospital of Pittsburgh (1)
More research sites in Philadelphia
- University of Pennsylvania (357 trials)
- Children's Hospital of Philadelphia (306 trials)
- Thomas Jefferson University Hospital (112 trials)
- Thomas Jefferson University (95 trials)
- Fox Chase Cancer Center (94 trials)
- Hospital of the University of Pennsylvania (87 trials)
- The Children's Hospital of Philadelphia (42 trials)
- Temple University (39 trials)
- Temple University Hospital (38 trials)
- University of Pennsylvania/Abramson Cancer Center (30 trials)
Explore more
Paid clinical trials in Philadelphia, PA · Pennsylvania clinical trials